Analysed CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) News Sources
Calidi Biotherapeutics Presents New Data on CLD-501, Its In Situ T-Cell Engager Candidate Targeting TROP-2 at the T-Cell Engager Therapeutic Summit
24-06-2026
yahoo.com
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711
08-07-2026
yahoo.com
Calidi Announces Reverse Stock Split, Expected to Begin Trading on a 1-for-16 Split Adjusted Basis on July 31, 2026
20-07-2026
yahoo.com
Calidi Biotherapeutics Provides Mid-Year Corporate Update and Future Key Value Drivers
21-07-2026
yahoo.com
Calidi Biotherapeutics Presents New Data on Cytotoxicity and IL-15 SA Expression in Human and Murine Tumor Cells at the American Association for Cancer Research Drug Discovery and Development Conference
27-07-2026
yahoo.com
Calidi Biotherapeutics Reports Second Quarter 2026 Financial Results and Recent Business Highlights
13-08-2026
yahoo.com
Calidi Biotherapeutics to Participate in the H.C. Wainwright 28th Annual Global Investment Conference
08-09-2026
yahoo.com
Calidi Biotherapeutics Received NYSE American Notification Letter Regarding Stockholders’ Equity Deficiency
25-09-2026
yahoo.com
What is the current price of CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS)?
The current price of CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) is $0.
CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) absolute price change since previous trading day?
The absolute price change of CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) since the previous trading day is $None.
CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) percentage price change since previous trading day?
The percentage price change of CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) since the previous trading day is None%.
What is the most recent average sentiment score for CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS)?
The most recent average sentiment score for CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) is 73 out of 100.
What is the most recent average sentiment for CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS)?
The most recent sentiment for CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS) is .
SEC-8K** Filing Available For CALIDI BIOTHERAPEUTICS -CW23 (CLDWW:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.